La Jolla biotech company Anaphore said Jan. 7 it raised $25 million in a Series A financing round.
5AM Ventures, Versant Ventures and Apposite Capital led the round.
Anaphore will use the proceeds to speed development of a new class of protein therapeutics, dubbed Atrimers, that address unmet medical needs in the areas of cancer and immune-mediated diseases.
Anaphore was created through the acquisition of Danish biotech firm Borean Pharma ApS, a company with a technology for creating improved protein therapeutics.
- Advertisement -
, Heather Chambers
